Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Explore the critical factors to consider when choosing no fee travel cards. Ensure your card fits your travel needs.
24,592 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Tariffs roiled markets, sending GLD down as real interest rates climbed and inflation stayed sticky. The gold ETF rem...
Analysts warn that Nvidia's GTC event may not deliver the dramatic stock move some investors were banking on. The con...
Bitcoin's long-term holder realized supply remains elevated near peak levels even as prices pause. Analysts say the c...
A Sydney-based tech founder uses AI to design a bespoke cancer vaccine for his dog, Rosie, signaling a new frontier i...
MoxiWorks has renewed its strategic partnership with Michael Saunders & Company to boost AI-driven marketing across t...
Kalshi locks billion valuation as a $1B round led by Coatue pushes the U.S. prediction market leader to a $22B valuat...
FuboTV's reverse stock split reduces outstanding Class A and Class B shares, triggering a debate among retail investo...
Meta has slashed about 25,000 jobs since 2022, with 700 more in Reality Labs this week. The moves spotlight a leaders...
IonQ is set to release Q1 2026 results after the bell, with investors weighing growth across five acquisitions, a Sky...
A growing number of high-income workers are using in-plan roth conversion high strategies within 401(K) plans to dodg...
Brent crude charts flashed a pattern not seen in 36 years, triggering fresh volatility bets. Analysts say the rarity ...